首页> 外文会议>International Conference on the Scientific and Clinical Applications of Magnetic Carriers >Nanoparticles of Molybdenum Chlorophyllin Photosensitizer and Magnetic Citrate-Coated Cobalt Ferrite Complex Available to Hyperthermia and Photodynamic Therapy Clinical Trials
【24h】

Nanoparticles of Molybdenum Chlorophyllin Photosensitizer and Magnetic Citrate-Coated Cobalt Ferrite Complex Available to Hyperthermia and Photodynamic Therapy Clinical Trials

机译:钼叶绿素光敏剂和磁性柠檬酸钴铁氧体复合物可用于热疗和光动力治疗临床试验

获取原文

摘要

This study report on the synthesis and characterization of molybdenum chlorophyllin (Mo-Chl) compounds associated in a complex with magnetic nanoparticles (citrate-coated cobalt ferrite), the latter prepared as a biocompatible magnetic fluid (MF). The complex material was developed for application as a synergic drug for cancer treatment using Photodynamic Therapy (PDT) and Hyperthermia (HPT). Chlorophyllin was obtained from alkaline extraction of Ilex paraguariensis following molybdenum insertion from hydrolysis with molybdate sodium. Fluorescence quantum yield (Φ_f) of Mo-Chl/dimethyl-sulphoxide (DMSO) was lower than 0.1, with a lifetime of 5.0 ns, as obtained from time-correlated single-photon counting technique. The oxygen quantum yield of Mo-ChI was carried out using laser flash-photolysis studies in homogeneous medium saturated with O_(2(g)) (Φ_Δ = 0.50). Cellular viability was also evaluated via the classical MTT assay using gingival fibroblasts cells as a biological model. Studies performed with the complex Mo-Ch1(5.0 μmol.L~(-1))/MF at different magnetic nanoparticle concentrations (ranging from 10~(12) to 10~(15) particle.mL~(-1)) revealed a cellular viability of approximately 95% for the ideal magnetic material concentration of 1 x 10~(13) particle.mL~(-1). The present study shows that natural photosensitizers molecules Mo-ChI used in association with magnetic nanoparticles represent a promising generation of drug developed to work synergistically in the treatment of neoplastic tissues using PDT and HPT.
机译:该研究报告了在磁性纳米粒子(柠檬酸盐钴铁氧体)中复合物中钼叶绿素(MO-CHL)化合物的合成和表征的合成和表征,后者作为生物相容性磁流体(MF)。使用光动力治疗(PDT)和高温(HPT)为癌症治疗的应用作为癌症治疗的合酶治疗的复杂材料。在用钼酸钼水解中,从钼插入后的ILEX Paraguariensis的碱性提取获得叶绿素。如从时间相关的单光子计数技术获得的那样,Mo-CHL /二甲基 - 硫氧化物(DMSO)的荧光量子产率(φ_f)低于0.1,寿命为5.0ns。使用用O_(2(g))(2(g))(φ_δ= 0.50)饱和的均匀介质中的激光闪光光解性研究进行MO-Chi的氧量子产率。还通过使用牙龈成纤维细胞作为生物学模型,通过经典MTT测定评估细胞活力。在不同磁性纳米颗粒浓度下用复合MO-CH1(5.0μmol.L〜(-1))/ MF进行的研究(范围为10〜(12)至10〜(15)颗粒。〜(-1))显示对于1×10〜(13)颗粒的理想磁性材料浓度约95%的细胞活力.ML〜(-1)。本研究表明,与磁性纳米粒子结合使用的自然光敏剂分子MO-CHI代表了一种有望的药物,其在使用PDT和HPT治疗肿瘤组织的治疗中发展起来的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号